| Jennifer Lynn Watkins, BSN, RN, IBCLC | |
|
8361 E Main St, Alexandria, KY 41001 | |
| (859) 242-2740 | |
| Not Available |
| Full Name | Jennifer Lynn Watkins |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Lactation Consultant |
| Location | 8361 E Main St, Alexandria, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447937347 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WL0100X | Registered Nurse - Lactation Consultant | L-126674 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Lynn Watkins, BSN, RN, IBCLC 10 Shadow Wood Ct, Alexandria, KY 41001-4316 Ph: (513) 295-4124 | Jennifer Lynn Watkins, BSN, RN, IBCLC 8361 E Main St, Alexandria, KY 41001 Ph: (859) 242-2740 |
News Archive
Acetylon Pharmaceuticals today announced the initiation of patient treatments in a three-part Phase 1-2a clinical trial of ACY-1215, an oral Class II histone deacetylase (HDAC) inhibitor, in adults with relapsed and relapsed/refractory multiple myeloma.
New polls indicate that, even as the Obama administration hustles to fix healthcare.gov's troubles, the overhaul appears to be a drag on Americans' confidence in President Barack Obama.
Dermatopathologist, Jodi J. Speiser MD, Assistant Professor of Pathology, Loyola University Stritch School of Medicine, has been named one of the American Society for Clinical Pathology's "40 Under 40" for her achievements in the medical laboratory field.
[M]illions of Americans [are] already exploring realities of the health-care overhaul, provisions likely to remain in place even as lawmakers threaten to repeal or defund it. Several key measures began taking effect for insurance plans written or renewed starting in September. More are scheduled for 2011, some benefiting consumers directly, others affecting insurance companies in various ways (Conaboy/Avril, 1/2).
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).
› Verified 4 days ago
Terri Angel, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1075 Parkside Dr, Alexandria, KY 41001 Phone: 859-391-6117 | |
Craig Fox, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 158 Lake Park Dr, Alexandria, KY 41001 Phone: 859-912-9502 | |
Cynthia L Tufarella, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 8333 Alexandria Pike, Alexandria, KY 41001 Phone: 859-694-4000 Fax: 859-694-4200 | |
Ms. Charlotte Savill, BSN RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7936 Arcadia Blvd, Alexandria, KY 41001 Phone: 513-304-0407 | |
Rhiannon Marie Feltner, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Maple Valley Ln, Alexandria, KY 41001 Phone: 859-512-1220 |